Serum and cellular biologic tumor markers in testicular cancer

During the past two decades, a dramatic improvement has been made in the treatment of testicular germ cell tumor. This progress has been due to finding more efficacious systemic chemotheraeutic agents and the availability of specific and sensitive biologic tumor markers to detect early recurrence and monitor the therapy. In this review, I will update my 15 years of experience in establishing and utilization of these serum and cell markers in testicular cancer